UroGen Pharma Ltd.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC URGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

403

Value ($000)

9

Weight

0.0%

2019 Q4 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	9	0.0%	403	12/31/2025
2025 Q1	5/19/2025	48,227	0.0%	4,360,524	3/31/2025
2024 Q4	2/14/2025	14,667	0.0%	1,377,156	12/31/2024
2024 Q3	11/14/2024	17,032	0.0%	1,341,072	9/30/2024
2024 Q2	8/14/2024	22,150	0.0%	1,320,000	6/30/2024
2022 Q1	5/16/2022	195	0.0%	22,400	3/31/2022
2021 Q4	2/14/2022	213	0.0%	22,400	12/31/2021
2021 Q3	11/15/2021	377	0.0%	22,400	9/30/2021
2021 Q2	8/16/2021	342	0.0%	22,400	6/30/2021
2021 Q1	5/14/2021	436	0.0%	22,400	3/31/2021
2020 Q4	3/1/2021	404	0.0%	22,400	12/31/2020
2020 Q3	11/13/2020	432	0.0%	22,400	9/30/2020
2020 Q2	8/14/2020	499	0.0%	19,101	6/30/2020
2020 Q1	5/15/2020	389	0.0%	21,801	3/31/2020
2019 Q4	2/14/2020	547	0.0%	16,401	12/31/2019